期刊
JOURNAL OF CONTROLLED RELEASE
卷 189, 期 -, 页码 141-149出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2014.06.048
关键词
DNA delivery; Amphipathic peptide; Nanoparticle; Cell penetrating peptide; Biological barriers
资金
- Royal Society [RG2010R2]
- Cancer Research UK [A13800, A14271]
- BBSRC [BB/I006958/1] Funding Source: UKRI
- MRC [MC_PC_13075] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/I006958/1] Funding Source: researchfish
- Medical Research Council [MC_PC_13075] Funding Source: researchfish
The design of a non-viral gene delivery vehicle capable of delivering and releasing a functional nucleic acid cargo intracellularly remains a formidable challenge. For systemic gene therapy to be successful a delivery vehicle is required that protects the nucleic acid cargo from enzymatic degradation, extravasates from the vasculature, traverses the cell membrane, disrupts the endosomal vesicles and unloads the cargo at its destination site, namely the nucleus for the purposes of gene delivery. This manuscript reports the extensive investigation of a novel amphipathic peptide composed of repeating RALA units capable of overcoming the biological barriers to gene delivery both in vitro and in vivo. Our data demonstrates the spontaneous self-assembly of cationic DNA-loaded nanoparticles when the peptide is complexed with pDNA. Nanoparticles were <100 nm, were stable in the presence of serum and were fusogenic in nature, with increased peptide alpha-helicity at a lower pH. Nanoparticles proved to be non-cytotoxic, readily traversed the plasma membrane of both cancer and fibroblast cell lines and elicited reporter-gene expression following intravenous delivery in vivo. The results of this study indicate that RALA presents an exciting delivery platform for the systemic delivery of nucleic acid therapeutics. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据